Cartesian Therapeutics Inc
SWB:1S7
Cartesian Therapeutics Inc
SWB:1S7
Price:
13.242
EUR
Market Cap:
€8.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cartesian Therapeutics Inc
SWB:1S7
|
US |
|
Central Omega Resources Tbk PT
IDX:DKFT
|
ID |
|
C
|
Crown Holdings Inc
LSE:0I4X
|
US |
|
W
|
Wendys Co
XMUN:TQK
|
US |
|
C
|
Coffee Holding Co Inc
F:E6U
|
US |
|
S
|
Schoeller Bleckmann Oilfield Equipment AG
DUS:SLL
|
AT |
|
C
|
China Resources Cement Holdings Ltd
OTC:CJRCF
|
HK |
|
A
|
Atea ASA
XBER:MKL
|
NO |
|
Planet Labs PBC
NYSE:PL
|
US |
|
T
|
Terna Rete Elettrica Nazionale SpA
SWB:UEI
|
IT |
|
KBC Groep NV
XBRU:KBC
|
BE |
|
D
|
Dycom Industries Inc
SWB:DYI
|
US |
|
H
|
H2O Innovation Inc
PAR:ALHEO
|
CA |
Wall St Price Targets
1S7 Price Targets Summary
Cartesian Therapeutics Inc
Cartesian Therapeutics Inc
Wall Street analysts forecast 1S7 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 1S7 is 54.939 EUR with a low forecast of 25.475 EUR and a high forecast of 72.831 EUR.
Lowest Forecast
Price Target
25.475
EUR
92% Upside
Average Forecast
Price Target
54.939
EUR
315% Upside
Highest Forecast
Price Target
72.831
EUR
450% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1S7's stock price target?
Price Target
54.939
EUR
54.939
EUR
According to Wall Street analysts, the average 1-year price target for 1S7 is 54.939 EUR with a low forecast of 25.475 EUR and a high forecast of 72.831 EUR.
What is the Revenue forecast for Cartesian Therapeutics Inc?
Projected CAGR
105%
105%
Over the last 10 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 8 years is 105%.
